Cargando…

Distinct Molecular Mechanisms Characterizing Pathogenesis of SARS-CoV-2

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has continued for over 2 years, following the outbreak of coronavirus-19 (COVID-19) in 2019. It has resulted in enormous casualties and severe economic crises. The rapid development of vaccines and therapeutics against SARS-Co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Su Jin, Kim, Yu-Jin, Ahn, Dae-Gyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Microbiology and Biotechnology 2022
Materias:	Special Topic-COVID-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628960/ https://www.ncbi.nlm.nih.gov/pubmed/36039385 http://dx.doi.org/10.4014/jmb.2206.06064

Ejemplares similares

Neurological Complications of SARS-CoV, MERS-CoV, and COVID-19
por: Alshebri, Munirah Saad, et al.
Publicado: (2020)

A cluster of tertiary transmissions of 2019 novel coronavirus (SARS-CoV-2) in the community from infectors with common cold symptoms
por: Kim, Nam Joong, et al.
Publicado: (2020)

Are the COVID-19’s vaccines efficient on the most dangerous variant of SARS-CoV-2?
por: Davoodi, Poorya, et al.
Publicado: (2021)

Air filtration and SARS-CoV-2
por: Nazarenko, Yevgen
Publicado: (2020)

Infections sévères à SARS-CoV-2
por: Taghboulit, N., et al.
Publicado: (2021)

SARS-CoV-2 vaccine challenge based on spike glycoprotein against several new variants
por: Syahniar, Rike, et al.
Publicado: (2022)

Association between stopping universal SARS-CoV-2 admission testing and hospital-onset SARS-CoV-2 in England and Scotland
por: Pak, Theodore, et al.
Publicado: (2023)

Predicting SARS-CoV-2 Asymptomatic Infection Rate of Inpatients: A Time Series Analysis
por: Rivera, Frida, et al.
Publicado: (2021)

The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression
por: Pivniouk, Vadim, et al.
Publicado: (2022)

The SARS-CoV-2 Outbreak: an Epidemiological and Clinical Perspective
por: Wong, Rebecca S. Y.
Publicado: (2020)

Diaphragmatic myoclonus due to SARS-CoV-2 infection
por: Borroni, Barbara, et al.
Publicado: (2020)

SARS-CoV-2, an Underestimated Pathogen of the Nervous System
por: Jakhmola, Shweta, et al.
Publicado: (2020)

SARS-CoV-2 vaccine-related neurological complications
por: Oonk, Nicol G. M., et al.
Publicado: (2022)

A Cluster of Aspergillosis Associated with SARS-CoV-2
por: VerLee, Kerrie, et al.
Publicado: (2021)

Mitigation Strategies to Reduce Aerosolization of SARS-CoV-2
Publicado: (2022)

Commercial immunoglobulin products contain cross-reactive but not neutralizing antibodies against SARS-CoV-2
por: Ahn, Terrie S., et al.
Publicado: (2021)

Model-based cost-effectiveness analysis of oral antivirals against SARS-CoV-2 in Korea
por: Jo, Youngji, et al.
Publicado: (2022)

Assessment on anti-SARS-CoV-2 receptor-binding domain antibodies among CoronaVac-vaccinated Indonesian adults
por: Jo, Juandy, et al.
Publicado: (2022)

The Evidence for High-Titer Convalescent Plasma in SARS-CoV-2
por: Fisher, David L., et al.
Publicado: (2021)

Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel
por: Reicher, Shay, et al.
Publicado: (2021)

Broken Heart (Takotsubo) Syndrome Triggered by SARS-CoV-2
por: Finsterer, Josef
Publicado: (2021)

Asthma and viruses: A focus on rhinoviruses and SARS-CoV-2
por: Padayachee, Yorissa, et al.
Publicado: (2021)

Seroepidemiology of SARS-CoV-2, Yamagata, Japan, June 2020
por: Morikane, Keita, et al.
Publicado: (2021)

Cognitive phenotyping of post-infectious SARS-CoV-2 patients
por: Aiello, Edoardo Nicolò, et al.
Publicado: (2022)

Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19
por: Song, Kyoung-Ho, et al.
Publicado: (2021)

Dying with SARS-CoV-2 infection—an autopsy study of the first consecutive 80 cases in Hamburg, Germany
por: Edler, Carolin, et al.
Publicado: (2020)

Animal Models to Study Emerging Technologies Against SARS-CoV-2
por: Mullick, Jhinuk Basu, et al.
Publicado: (2020)

Protective Effects of CVD and DM Medications in SARS-CoV-2 Infection
por: Bangi, Shifa, et al.
Publicado: (2020)

SARS-CoV-2-Related Kidney Injury: Current Concern and Challenges
por: Cheng, Yongqian, et al.
Publicado: (2020)

Important Steps to Control COVID-19/SARS-CoV-2 Infection
por: Chatterjee, Sudipto
Publicado: (2020)

First motor seizure as presenting symptom of SARS-CoV-2 infection
por: Fasano, Antonio, et al.
Publicado: (2020)

Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2
por: Iroegbu, Joy D., et al.
Publicado: (2020)

Reversible conduction block of peroneal nerve associated with SARS-CoV-2
por: Cioffi, Ettore, et al.
Publicado: (2021)

The utility of SARS‐CoV‐2‐specific serology in COVID‐19 diagnosis
por: Hasan, Tasnim, et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 Antibody in Healthcare Workers in Central Pennsylvania
por: Kwon, Taesung, et al.
Publicado: (2021)

Age-specific contribution of contacts to transmission of SARS-CoV-2 in Germany
por: Rodiah, Isti, et al.
Publicado: (2023)

Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 Pneumonia
por: Trunfio, Mattia, et al.
Publicado: (2022)

HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome
por: Gigli, Gian Luigi, et al.
Publicado: (2020)

Colitis as a Sole Presentation of SARS-CoV-2 Infection: Case Report
por: Jaijakul, Siraya
Publicado: (2020)

Portal Vein Thrombosis—a Rare Complication of SARS-CoV-2 Infection
por: Sharma, Neeraj, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d4050i1eu7rl7nu90nrclebuic